Featured
Calls for PBS co-payment freeze
A peak industry body is calling on the Federal Government to freeze the general PBS co-pay price until 2030, naming the Top 5 medicines that have benefited from lower out-of-pocket costs for Australians
Latest
Aussies team up with Japanese giant
Strategic deal signed to bring pharmaceutical-grade cellular health compounds to the Australian market with multi million-dollar revenue potential
Industry & Companies
Which pharma nets $1.4M... every 20 minutes?
An analysis of the world's top 200 companies reveals three pharmas are raking in seven-figures in net profit in under half an hour. Find out how fast your company makes US$1M
Industry & Companies
The pharma influencer adding emotion to data
From a standing ovation in Chicago to your screen in less than a day, a novel way to learn about the exciting conference sessions that are relevant to Australia
Jobs & Workplace
Long-timers jump to new companies
After more than a decade with the same company, these executives are moving on. Find out the latest appointments across industry
Leadership & People
How Dolly quietly reshaped pharma
Dolly Parton released 25 hit singles, but it was her philanthropy efforts that made her a superstar in pharma, helping launch a first-of-its kind drug that became a household name around the world
Regulatory & Reimbursement
First treatment funded through new pathway
Rare disease patient has received treatment otherwise unavailable in Australia thanks to a new Innovative Therapies Pathway - and it only took six weeks
Featured
Who will survive the next pharma downsize?
A brutal downsizing is coming to pharma with a broad range of roles simply ceasing to exist. Australian experts have revealed the skills and capabilities needed to survive
Featured
Salary rift emerges across pharma
There is a growing divide in Australian pharma between what companies want to pay and what workers are willing to accept with the fallout being felt across industry
Jobs
Regulatory & Reimbursement
PBAC July meeting winners and losers
Almost three-quarters of the new PBS listing submissions considered by PBAC in July won green light, but some big names drugs were delivered a blow
Regulatory & Reimbursement
PBAC says no to higher price for blockbuster
Company 'disappointed' after the PBAC knocked back a revised submission for this much-needed biologic due to price
Industry & Companies
Aussie jobs to go after trial failure
Dose-limiting toxicities has scuppered an otherwise promising cancer program, seeing a local company cut jobs and scope out possible ways to remain a going concern
Industry & Companies
Roche muscles up with $3.2B weight loss play
The company has put money down for a potential first-in-class rival in the lucrative obesity space for an asset that allows patients to shed kilos but preserves muscle
- Regulatory & Reimbursement EU tick paves way for bumper payday
- Regulatory & Reimbursement Pfizer touts Australian results
- Other News AI tool builds synthetic patients and HCPs for pharma
- Other News Gene therapy may prevent heart transplants in kids
- Regulatory & Reimbursement New antibiotic arrives in Australia
- Other News Pharma PR campaigns shortlisted for awards
- Leadership & People GSK prize marks revolution in respiratory care
- Regulation & Legal TGA dishes five-figure prescription drug fine
- Regulation & Legal Black market booms for future blockbuster
- Other News Who's got a new job at an old company?
